The best way to get Mounjaro: what actually works in the UK

You've found Mounjaro online and you're wondering who can actually prescribe it

That's the starting point for most people who search this question. You've read about the results, maybe seen someone post about it, and now you want to know the real process rather than wade through vague or conflicting information.

Mounjaro is tirzepatide: a once-weekly injection that works on two gut-hormone receptors simultaneously (GIP and GLP-1) to reduce appetite and slow digestion. It is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above if a weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea is present. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

Because it is a Prescription-Only Medicine, the question of where to get it begins and ends with clinical assessment. A prescriber reviews your health history, current medications, BMI and relevant conditions, then decides whether Mounjaro is suitable. That step is not a formality; it is the thing that makes your treatment safe. The full Mounjaro overview covers how the medicine works and what to expect during treatment.

The NHS route: real eligibility, real waiting times

NHS England is rolling out tirzepatide in phases, and eligibility right now is narrow. From June 2025, adults with a BMI of 40 or above plus four or more of five specific conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease or type 2 diabetes) could access treatment. A second cohort, covering BMI 35–39.9 with four or more of those conditions, became eligible in June 2026. Further cohorts are planned into 2027.

Even if you meet the criteria, access depends on whether your GP practice is participating in the new prescribing arrangements, and you must take part in structured lifestyle support alongside the medicine. NHS England's guidance on weight-management injections sets out exactly what this involves, including advice on contraception and surgery that every patient should read.

For many people the NHS route either does not apply yet or involves a wait they are not able to sit through. That is where the private route becomes relevant, provided you use a regulated provider.

The private route: what a legitimate provider actually does

A regulated private pathway starts with a clinical consultation. At nume, that consultation is free, reviewed the same day by a GPhC-registered Independent Prescriber (a real clinician, not software) and includes photo-ID verification and live weight confirmation on video. If the prescriber approves treatment, your medicine is dispatched the same day (for orders placed before 12pm Monday to Friday) and arrives the next working day in plain, unbranded packaging via DPD tracked delivery.

Worth noting for timing: if you order on a Friday before 12pm, your pen will arrive Monday. Order on Christmas Eve and the same public-holiday rules apply. Monday orders placed before 12pm tend to be the most predictable for people who like to plan around work.

One transparent price covers the consultation, prescription, medicine and delivery. There are no add-on fees and no subscription, every repeat order is reviewed clinically before it goes out. For context on what private treatment costs across the market, the Mounjaro price guide explains how pricing works and what to watch for in a quote that looks unusually low.

You can verify any online pharmacy on the GPhC register in under a minute. For a medicine dispensed by injection into your body, that check is worth doing.

Red flags to avoid and how the MHRA describes the risk

The MHRA has publicly warned about fake weight-loss pens sold through social media and unverified websites. Enforcement operations have uncovered large-scale illicit supply (including a site in Northampton raided in October 2025 producing counterfeit tirzepatide pens) and some counterfeit pens have been found to contain insulin rather than the labelled medicine, so if you are also researching which tirzepatide peptide company is actually legitimate, that context matters. The human consequences can be serious.

The pattern the MHRA describes is consistent: sellers offering these medicines without a prescription, prices significantly below the market range, and discount codes used to create urgency. If you see those signs together, treat them as a reliable warning. You can report a suspect seller directly through the MHRA Yellow Card scheme.

The safest practical step (beyond using a prescriber-led service) is confirming GPhC registration before you hand over any personal or payment information. Our guide to choosing where to get Mounjaro covers the verification steps in detail.

When you are ready to look at your own eligibility, the free consultation is where that conversation starts, and if you are thinking ahead to how you will eventually come off the medicine, our guide on the best way to stop Mounjaro is worth reading before you begin.